Berman Capital Advisors’s Integra LifeSciences IART Stock Holding History

Berman Capital Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$13K	Buy	204 +31	+18%	+$2.19K	﹤0.01%	1100
2021 Q2	$11K	Hold	173	–	–	﹤0.01%	1110
2021 Q1	$11K	Hold	173	–	–	﹤0.01%	1001
2020 Q4	$11K	Sell	173 -35	-17%	-$1.88K	﹤0.01%	882
2020 Q3	$9K	Buy	208 +122	+142%	+$5.8K	﹤0.01%	832
2020 Q2	$4K	Buy	86 +63	+274%	+$3.1K	﹤0.01%	1056
2020 Q1	$1K	Hold	23	–	–	﹤0.01%	1307
2019 Q4	$1K	Hold	23	–	–	﹤0.01%	1331
2019 Q3	$1K	Hold	23	–	–	﹤0.01%	1319
2019 Q2	$1K	Hold	23	–	–	﹤0.01%	1330
2019 Q1	$1K	Buy	+23	New	+$1.17K	﹤0.01%	1213

Other funds holding IART

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Berman Capital Advisors's IART Position: Q3 2021 in Review

Berman Capital Advisors increased its Integra LifeSciences (IART) stake by 18% in Q3 2021, buying an estimated $2.19K and bringing the position to 204 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #1100.

Berman Capital Advisors first reported a position in IART in Q1 2019 and has held it in 11 quarters since. 261 funds tracked by Wall St. Rank hold IART as of Q3 2021.

Berman Capital Advisors held 204 shares of Integra LifeSciences worth $13K as of Q3 2021.
Berman Capital Advisors bought 31 Integra LifeSciences shares in Q3 2021, an estimated $2.19K.
Integra LifeSciences made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1100 holding.
Berman Capital Advisors first reported a position in Integra LifeSciences in Q1 2019 and has held it in 11 quarters since.
261 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.